Pharmacy Chain 36.6 Reports FY2009 Audited IFRS Results
OREANDA-NEWS. July 02, 2010. OJSC Pharmacy Chain 36.6 [RTS:APTK;MICEX:RU14APTK1007] — the leading Russian pharmaceutical retailer announces audited FY 2009 and unaudited Q4 2009 financial results prepared in accordance with the International Financial Reporting Standards (IFRS).
Group highlights of 2009
Group revenue from ongoing operations1 decreased by 17.4% to RUR 21 061.5 mln as compared with FY2008;
Gross profit from ongoing operations1 decreased by 5.2% to RUR 8 301.4 mln and equaled to 39.4% of consolidated revenues;
Consolidated EBITDA from ongoing operations1 reached RUR 1 421.6 mln compared with RUR 699.9 mln in
Group Net loss decreased from RUR 1 640.8 mln in 2008 to RUR 359.4 mln in
Underlying Net loss from ongoing operations1 (excluding sale of investments, disposal of discontinued operations, foreign exchange effect and gain on minority interest restructuring) decreased from RUR 1 782.2 mln in 2008 to RUR 821.3 mln in
The retail unit organically opened 23 stores and closed 131 stores in 2009.
Retail unit
Revenue
As compared to the relative period the year before, in 2009 sales of the Retail unit decreased by 23.3% in ruble terms from RUR 20 837.4 mln to RUR 15 984.8 mln driven by the closure of non-performing stores, partial shortages of products as a result of working capital decline and decrease in customer demand. In Q4 2009 versus Q4 2008 sales of the Retail unit decreased by 28.7% from RUR 5 071.9 mln to RUR 3 618.4 mln. In Q4 2009 versus Q3 2009 sales of the Retail unit increased by 2.5%.
Like-for-like sales2 in 2009 versus 2008 decreased by 17% in ruble terms driven by partial stock-outs and decline in customer traffic. L-f-L average check in 2009 compared with 2008 increased by 11% in ruble terms;traffic decreased by 25%. In Q4 2009 versus Q4 2008 L-f-L sales decreased by 21% in ruble terms, average check increased by 6% in ruble terms, traffic declined by 26%.
Gross margin
In 2009 gross margin in the Retail unit increased by 3.9% to 32.0% from 28.1% in 2008. Such significant growth was achieved by an increased share of Private label goods in retail sales, successful commercial activity in price-cuts from suppliers, improvement of pricing and assortment policies. In Q4 2009 gross margin increased by 2.7% to 33.3% from 30.6% in Q4 2008. Compared to Q3 2009, gross margin increased by 1.0%.
Selling, general and administrative expenses
Selling, general and administrative expenses dropped by 20.4% in ruble terms from RUR 6 841.5 mln in 2008 to RUR 5 443.1 mln in 2009 due to continuous implementation of the cost optimization programme. In Q4 2009, selling, general and administrative expenses decreased by 26.5% to RUR 1 278.6 mln from RUR 1 740.4 mln in Q4 2008. Compared with Q3 2009, SG&A costs decreased by 0.5%.
Despite the decrease in absolute numbers of SG&A costs, their share in overall sales increased by 1.0% in Q4 2009 compared with Q4 2008, and by 1.3% in 2009 compared with 2008 due to decline in revenues.
Trade accounts payable
Compared with 2008, trade accounts payable decreased by 37.5% from RUR 5 667.2 mln to RUR 3 540.1 mln in 2009 due to part of accounts payable recovery. Versus Q3
Inventory
Average days of turnover increased from 62 days at the end of Q4 2008 to 75 days as of the end of Q4 2009. Compared with Q3 2009 as at the end of Q4 2009 average days of turnover increased from 70 up to 75 days due to reduced level of seasonal sales in December 2009.
In absolute terms, inventory was reduced by 12.7% to RUR 2 336.4 mln as of the end of Q4 2009 compared with RUR 2 677.1 mln as of the end of Q4 2008.
Other businesses
Veropharm
For the latest update on FY 2009 performance please refer to the official press-release of the company as of May 13th, 2010.
ELC
Early
As of the end of Q4 2009, the unit operated 13 stores.
Group financial debt
Group Financial Debt at the end of Q4 2009 increased by 69.5% to RUR 7 441.1 mln from RUR 4 389.2 mln at the end of Q4 2008 and from RUR 5 135.4 mln at the end of Q3 2009 as a result of converting minority interest into a long-term debt. At the end of Q4 2009, the Retail unit debt stood at RUR 6 488.2 mln with RUR 4 110.8 mln (63.4%) denominated in dollars.
Group financial costs
In 2009 versus 2008 consolidated financial costs grew by 8.0% to RUR 1 174.0 mln due to the financial costs associated with financial debt restructuring and fulfillment of obligations to suppliers. In Q4 2009 compared with Q4 2008 financial costs decreased by 23.1% and reached RUR 286.2 mln.
Investments
In 2009 the Group invested in fixed assets and intangible assets RUR 239 mln, whereas retail investments stood at RUR 104 mln.
Group net profit
Underlying Net loss from ongoing operations (excluding sale of investments, disposal of discontinued operations, foreign exchange effect and gain on minority interest restructuring) decreased from RUR 555.7 mln in Q4 2008 to RUR 43.0 mln in Q4
Underlying Net loss from ongoing operations (excluding sale of investments, disposal of discontinued operations, foreign exchange effect and gain on minority interest restructuring) decreased from RUR 1 782.3 mln in 2008 to RUR 821.3 mln in
Group Net loss decreased from RUR 1 640.8 mln in 2008 to RUR 359.4 mln in
In 2009 restructuring of arrangement with consortium of investors was effected, which resulted in conversion of consortium share in Glazar Limited Company (reflected in FY 2008 results as a minority interest profit) together with a Standard Bank loan for the total amount of USD 25 mln into a USD 110 mln long-term debt with a maturity date till 2014. As a result, gain on restructuring of arrangement with consortium of investors in the amount of RUR 556.9 mln was reflected in consolidated profit and loss statement.
1 Ongoing operations’ results exclude operating results of EMC which was sold in May 2008.
2 The L-F-L reporting is executed for a selection of comparable stores, which are:
opened or acquired 24 months before the current reporting period, and
neither rebranded nor reformatted or somehow significantly changed during the last 24 months, and
not closed in the current reporting period.
3 The share, consolidated by the Group is correspondingly RUR 9.9 mln and RUR 8.6 mln.
Комментарии